Long-term maternal and child outcomes following postnatal SSRI treatment

About The Study: The results of this study of 61,000 mother-child dyads suggest that postnatal selective serotonin reuptake inhibitor (SSRI) treatment was associated with a reduced risk of postnatal depression–associated maternal mental health problems and child externalizing behaviors across early childhood years. These findings suggest that postnatal SSRI treatment may bring benefits in the long term to women with postnatal depression and their offspring.

Authors: Chaoyu Liu, M.D., Ph.D., of King’s College in London, is the corresponding author. 

 To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2023.31270)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.31270?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082923

 

END